AU2001268442A1 - Identification of cdnas associated with benign prostatic hyperplasia - Google Patents
Identification of cdnas associated with benign prostatic hyperplasiaInfo
- Publication number
- AU2001268442A1 AU2001268442A1 AU2001268442A AU6844201A AU2001268442A1 AU 2001268442 A1 AU2001268442 A1 AU 2001268442A1 AU 2001268442 A AU2001268442 A AU 2001268442A AU 6844201 A AU6844201 A AU 6844201A AU 2001268442 A1 AU2001268442 A1 AU 2001268442A1
- Authority
- AU
- Australia
- Prior art keywords
- identification
- benign prostatic
- prostatic hyperplasia
- cdnas associated
- cdnas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21272600P | 2000-06-20 | 2000-06-20 | |
| US60212726 | 2000-06-20 | ||
| PCT/US2001/019157 WO2001098456A2 (en) | 2000-06-20 | 2001-06-15 | IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268442A1 true AU2001268442A1 (en) | 2002-01-02 |
Family
ID=22792193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268442A Abandoned AU2001268442A1 (en) | 2000-06-20 | 2001-06-15 | Identification of cdnas associated with benign prostatic hyperplasia |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001268442A1 (en) |
| WO (1) | WO2001098456A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001268570A1 (en) * | 2000-06-16 | 2001-12-24 | Millennium Pharmaceuticals, Inc. | 33358, a novel human ankyrin family member and uses thereof |
| EP1565548A2 (en) * | 2002-11-25 | 2005-08-24 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| US7700334B2 (en) | 2003-08-12 | 2010-04-20 | Lawrence Livermore National Security, Llc | Photoswitchable method for the ordered attachment of proteins to surfaces |
-
2001
- 2001-06-15 AU AU2001268442A patent/AU2001268442A1/en not_active Abandoned
- 2001-06-15 WO PCT/US2001/019157 patent/WO2001098456A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001098456A2 (en) | 2001-12-27 |
| WO2001098456A3 (en) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001259672A1 (en) | Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristics | |
| AU2001236731A1 (en) | Transurethral volume reduction of the prostate (tuvor) | |
| AU1316000A (en) | Compositions and methods for treating benign prostatic hyperplasia using tocotrienols | |
| SI0968208T1 (en) | Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia | |
| AU3011299A (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2002243446A1 (en) | Method of making hydrofluorocarbons and hydrochlorofluorocarbons | |
| AUPQ923100A0 (en) | Treatment of prostate cancer | |
| AU2001288360A1 (en) | Genomics-assisted rapid identification of targets | |
| AU2002211370A1 (en) | Inhibition of tgf-beta and uses thereof | |
| AU2002219900A1 (en) | Minimal identification of features | |
| ZA991315B (en) | Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. | |
| AU2001268442A1 (en) | Identification of cdnas associated with benign prostatic hyperplasia | |
| AU2000279176A1 (en) | Locking nail and target appliance | |
| AU2001283152A1 (en) | Identification of cdnas associated with benign prostatic hyperplasia | |
| AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
| AU2876000A (en) | Tyrosine kinase inhibitors and methods of using the same | |
| AU2002232403A1 (en) | Del-1 and benign prostatic hyperplasia | |
| GB0301016D0 (en) | Treatment of benign prostatic hyperplasia | |
| AU2002336520A1 (en) | Method of treating benign prostatic hyperplasia and other beingn porstate conditions | |
| AU2001235961A1 (en) | Integrated optical devices and methods of making such devices | |
| AU2002210683A1 (en) | Identification of hla-dr restricted hcv epitopes | |
| AU2002317553A1 (en) | Genes associated with benign prostatic hyperplasia | |
| AU2001278204A1 (en) | Methods of selecting and cloning animals | |
| GB2418985B (en) | Protein markers for human benign prostatic hyperplasia(BPH) |